# Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal

> **NCT00240344** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 2650 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00240344
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 2650 (ACTUAL)
- **Last updated:** 2011-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00240344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00240344, "Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00240344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*